| 苏同义 朱铁年 高冬梅 张怡梅 赵青兰.不同化疗方案对晚期非小细胞肺癌患者骨髓抑制及免疫功能的影响[J].,2014,14(21):4067-4070 |
| 不同化疗方案对晚期非小细胞肺癌患者骨髓抑制及免疫功能的影响 |
| Effect on Bone Marrow Suppression and Immune Function of DifferentChemotherapy Regimens in Patients withAdvanced non Small Cell Lung Cancer |
| |
| DOI： |
| 中文关键词: 晚期非小细胞肺癌 顺铂 长春瑞滨 吉西他滨 紫杉醇 |
| 英文关键词: Advanced non small cell lung cancer DDP Changchun vinorelbine Gemcitabine Docetaxel |
| 基金项目: |
|
| 摘要点击次数: 570 |
| 全文下载次数: 1090 |
| 中文摘要: |
| 目的：探讨不同化疗方案对晚期非小细胞肺癌患者骨髓抑制及免疫功能的影响。方法：选取2011 年1 月至2013年12月收
治的130例晚期非小细胞肺癌患者，按照知情同意原则随机分为三组：NP(长春瑞滨+顺铂)组45 例、GP(吉西他滨+顺铂)组43
例、TP(紫杉醇+顺铂)组42 例，分别于化疗前及化疗2 个周期后检测患者的骨髓抑制及免疫水平。结果：三种化疗方案进行治疗
后骨髓抑制水平由高到低排列为GP组、TP组、NP组，差异有统计学意义（P<0.05）；GP 组血小板减少发生率高于其他两组，TP 组
白细胞下降发生率高于其他两组，差异有统计学意义（P<0.05）；三组患者化疗后的免疫功能指标均较化疗前低，差异有统计学意
义（P<0.05）。三种化疗方案进行治疗后免疫功能抑制水平由高到低排列为GP组、TP组、NP组，差异有统计学意义（P<0.05）。结
论：GP 组患者血小板下降更明显，TP 组白细胞下降更为明显，NP 组对骨髓抑制及免疫功能抑制较缓和，更适于老年人，因此临床
选择化疗方案时要综合考虑患者骨髓状况、免疫功能情况及年龄等。 |
| 英文摘要: |
| Objective:To study the effect on bone marrow suppression and immune function of different chemotherapy regimens
in advanced non small cell lung cancer patient.Methods:130 cases of advanced non small cell lung cancer patients treated in our hospital
from January 2011 to December 2013 were selected and randomly divided into 3 groups according to the principle of informed consent:
NP group(Changchun vinorelbine plus DDP, n=45), GP group(Gemcitabine plus DDP, n=43)and TP group(Docetaxel plus DDP, n=42).
Bone marrow suppression and immune level were detected before the chemotherapy and after 2 cycles of the chemotherapy respectively.Results:The after-treatment bone marrow suppression levels of the three chemotherapy regimens ranked from high to low as GP group,
TP group and NP group, and the difference was statistically significant (P<0.05). The thrombocytopenia rate of GP group was higher than
the other two groups, the leucopenia rate of TP group was higher than the other two groups, the difference was statistically significant
(P<0.05). The immune function indicators of three groups after treatment were decreased than those before the treatment, the difference
was statistically significant (P<0.05). The immune function suppression levels of the three kinds of chemotherapy regimens after treatment
ranked GP group, TP group and NP group fromhigh to lowin order,the difference was statistically significant (P<0.05).Conclusion:The thrombocytopenia is more significant in group GP, the leucopenia is more significant in group TP, the effect on bone marrow suppression
and immune function of group NP is more moderate and suitable for the elderly. Therefore, the bone marrow status, immune
function and age of patients should be taken into consideration when clinical chemotherapy regimens are chosen . |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
